Dr. Angeles A. Secord
Claim this profileDuke University Medical Center
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
16 reported clinical trials
30 drugs studied
Area of expertise
1Ovarian Cancer
BRCA1 positive
FRα positive
Stage IV
2Fallopian Tube Cancer
FRα positive
Stage IV
BRCA positive
Affiliated Hospitals
Clinical Trials Angeles A. Secord is currently running
Megestrol + Metformin
for Endometrial Cancer Prevention
This phase II trial studies the effect of megestrol acetate alone or in combination with metformin in preventing the progression of uterine pre-cancer (endometrial intraepithelial neoplasia) to endometrial cancer. Megestrol acetate is a drug used to block estrogen and suppress the effects of estrogen and androgens. It is the current non-surgical treatment of endometrial intraepithelial neoplasia. Metformin is a drug that has been found to have anti-cancer properties. Giving metformin and megestrol acetate together may decrease the growth of endometrial intraepithelial neoplasia in the uterus better than megestrol alone.
Recruiting1 award Phase 214 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about Angeles A. Secord
Clinical Trial Related3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Angeles A. Secord has experience with
- Mirvetuximab Soravtansine
- Carboplatin
- Paclitaxel
- Olaparib
- Bevacizumab
- ZN-c3
Breakdown of trials Angeles A. Secord has run
Ovarian Cancer
Fallopian Tube Cancer
Endometrial Cancer
Ovarian Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Angeles A. Secord specialize in?
Angeles A. Secord focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved BRCA1 positive patients, or patients who are FRα positive.
Is Angeles A. Secord currently recruiting for clinical trials?
Yes, Angeles A. Secord is currently recruiting for 8 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Angeles A. Secord has studied deeply?
Yes, Angeles A. Secord has studied treatments such as Mirvetuximab Soravtansine, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Angeles A. Secord?
Apply for one of the trials that Angeles A. Secord is conducting.
What is the office address of Angeles A. Secord?
The office of Angeles A. Secord is located at: Duke University Medical Center, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.